-
Kenya's economy faces climate change risks: World Bank
-
US Fed expected to hold rates steady as Iran war roils outlook
-
It's 'Sinners' v 'One Battle' as Oscars day arrives
-
US mayors push back against data center boom as AI backlash grows
-
Who covers AI business blunders? Some insurers cautiously step up
-
Election campaign deepens Congo's generational divide
-
Courchevel super-G cancelled due to snow and fog
-
Middle East turmoil revives Norway push for Arctic drilling
-
Iran, US threaten attacks on oil facilities
-
Oscars: the 10 nominees for best picture
-
Spielberg defends ballet, opera after Chalamet snub
-
Kharg Island bombed, Trump says US to escort ships through Hormuz soon
-
Jurors mull evidence in social media addiction trial
-
UK govt warns petrol retailers against 'unfair practices' during Iran war
-
Mideast war cuts Hormuz strait transit to 77 ships: maritime data firm
-
How will US oil sanctions waiver help Russia?
-
Oil stays above $100, stocks slide tracking Mideast war
-
How Iranians are communicating through internet blackout
-
Global shipping industry caught in storm of war
-
Why is the dollar profiting from Middle East war?
-
Oil dips under $100, stocks back in green tracking Mideast war
-
US Fed's preferred inflation gauge edges down
-
Deadly blast rocks Iran as leaders attend rally in show of defiance
-
Moscow pushes US to ease more oil sanctions
-
AI agent 'lobster fever' grips China despite risks
-
Thousands of Chinese boats mass at sea, raising questions
-
Casting directors finally get their due at Oscars
-
Fantastic Mr Stowaway: fox sails from Britain to New York port
-
US jury to begin deliberations in social media addiction trial
-
NASA says 'on track' for Artemis 2 launch as soon as April 1
-
Valentino mixes 80s and Baroque splendour on Rome return
-
Dating app Tinder dabbles with AI matchmaking
-
Scavenging ravens memorize vast tracts of wolf hunting grounds: study
-
Top US, China economy officials to meet for talks in Paris
-
Chile's Smiljan Radic Clarke wins Pritzker architecture prize
-
Lufthansa flights axed as pilots walk out
-
Oil tops $100 as fresh Iran attacks offset stockpiles release
-
US military 'not ready' to escort tankers through Hormuz Strait: energy secretary
-
WWII leader Churchill to be removed from UK banknotes
-
EU vows to 'respond firmly' to any trade pact breach by US
-
'Punished' for university: debt-laden UK graduates urge reform
-
Mideast war to brake German recovery: institute
-
China-North Korea train arrives in Pyongyang after 6-year halt
-
Businessman or politician? Billionaire Czech PM under fire again
-
Lost page of legendary Archimedes palimpsest found in France
-
Cathay Pacific roughly doubles fuel surcharge on most routes
-
BMW profit holds up despite Trump tariffs, China woes
-
Electric vehicle rethink to cost Honda almost $16 billion
-
From Kyiv to UK, Ukrainian drone production spans Europe
-
Australia to change fuel quality standards to boost supply
'Ketamine Queen' to plead guilty over drugs that killed Matthew Perry
A dealer dubbed the "Ketamine Queen" has agreed to plead guilty to supplying the drugs that killed "Friends" actor Matthew Perry, the US Department of Justice said Monday.
Jasveen Sangha, 42, will admit several charges, including one of distribution of ketamine resulting in death or serious bodily injury in relation to the late star.
Sangha, who is expected to formally enter her pleas in the coming weeks, is a dual citizen of the United States and the United Kingdom. She has been in federal custody since August 2024.
She will become the fifth person to admit playing a part in the death of the beloved actor, who had openly struggled for decades with substance addiction.
Perry was found dead in the hot tub of his Los Angeles home in 2023 at the age of 54.
A criminal investigation was launched soon after an autopsy discovered he had high levels of ketamine -- an anesthetic -- in his system.
Last month Dr Salvador Plasencia pleaded guilty to four counts of distribution of ketamine in the weeks before Perry's death.
Another doctor, Mark Chavez, admitted last year to conspiring to distribute ketamine to Perry.
Plasencia allegedly bought ketamine off Chavez and sold it to the American-Canadian actor at hugely inflated prices.
"I wonder how much this moron will pay," Plasencia wrote in one text message.
According to her plea agreement, Sangha worked with a middleman, Erik Fleming, to sell 51 vials of ketamine to Perry's live-in personal assistant, Kenneth Iwamasa.
Iwamasa repeatedly injected Perry with the ketamine that Sangha supplied, including on October 28, 2023, when he administered at least three shots of Sangha's ketamine, which killed the actor.
The Department of Justice said when she heard news reports about Perry's sudden death, Sangha tried to cover her tracks.
"Delete all our messages," she instructed Fleming.
Perry had been taking ketamine as part of supervised therapy for depression.
But prosecutors say that before his death he became addicted to the substance, which also has psychedelic properties and is a popular party drug.
"Friends," which followed the lives of six New Yorkers navigating adulthood, dating and careers, drew a massive following and made megastars of previously unknown actors.
Perry's role as the sarcastic man-child Chandler brought him fabulous wealth, but hid a dark struggle with addiction to painkillers and alcohol.
In 2018, he suffered a drug-related burst colon and underwent multiple surgeries.
In his 2022 memoir "Friends, Lovers and the Big Terrible Thing," Perry described going through detox dozens of times.
"I have mostly been sober since 2001," he wrote, "save for about sixty or seventy little mishaps."
X.Cheung--CPN